Where does Covidien LP rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Covidien LP ranks #57 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Covidien LP hold?

Covidien LP holds 6,485 US utility patents granted between 2015 and 2025, spanning 183 technology areas.

What is Covidien LP's Innovation Score?

Covidien LP has an Innovation Score of 70.9 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Covidien LP focus on?

Covidien LP's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5,709 patents, ranking #1 of 7,127 assignees active in that subclass. Grants appear in 183 CPC subclasses total.

Is Covidien LP's patent grant rate increasing or decreasing?

Covidien LP's recent grant velocity is -13% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Covidien LP's patents?

Covidien LP's patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Covidien LP patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Covidien LP

USPTO PatentsView assignee record - 6,485 granted patents across 183 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Covidien ranks #57 of 49,997 tracked US assignees by granted-patent volume, with 6,485 patents across 183 technology areas.

#57
of 49,997 US assignees by volume: Top 1%
by Innovation Score (70.9/100): 16.2
avg claims per patent: -13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R57 · US Corporation #57 · 6,485 grants

GRANTS-LARGE · TOP-DECILE · CLEAR-GAP · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-LARGE 6.5K grants
TOP-DECILE #57/49,997
CLEAR-GAP The Regents of the…
CPC-WIDE A61B · 183 areas
INNOV-STRONG 70.9/100
CLAIMS-RICH 16.2 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -13% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: The Regents of the University of California (±57 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Covidien’s 70.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 30.3 pts (43%) Velocity 5.8 pts (8%) Breadth 25.0 pts (35%) Claim depth 9.7 pts (14%)

Qualcomm Incorporated · highest

85
Fraunhofer-Gesellsch… · near

71
Analog Devices… · near

71
Dish Network L L C · near

71
Covidien · this assignee

71
Honeywell Internatio… · near

71
3D Lighting… · lowest

7

What this shows Covidien's Innovation Score is 70.9/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Covidien?

Each dot is one of Covidien’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Covidien’s own 16.2 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Covidien vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Covidien's grant cadence moved

Between 2020–2024, Covidien LP received 2,880 grants versus 3,320 in 2015–2019 (-13% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2015 at 808 grants and bottomed in 2024 at 432. Lead class A61B accounts for 88% of the portfolio across 183 subclasses. Volume neighbours: Honeywell International Inc. (#53) and Capital ONE Services, LLC (#61).

Covidien's three-year grant acceleration

From 2019–2021 to 2022–2024, Covidien LP moved from 1,855 to 1,627 grants (0.88x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,568. See the growth leaderboard.

Honeywell Interna…

7,183
Siemens Aktienges…

7,003
Applied Materials

6,997
LG Chem

6,727
Covidien ◀

6,485
The Regents of th…

6,428
Saudi Arabian OIL

6,393
3M Innovative Pro…

5,993
Capital ONE Servi…

5,990

What this shows Covidien holds 6,485 patents at rank #57, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Covidien

By rank, the assignees closest to #57 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Covidien's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Covidien, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Covidien ranks #1 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (71 here).

Honeywell International Inc. 71 Dish Network L.L.C. 71 Analog Devices International Unlimited Company 71 Fraunhofer-Gesellschaft zur förderung der angewandten Forschung e.V. 71

Similar claim depth

Nearest assignees by average claims per patent (16.2 here).

Biomerieux, Inc. 16.2 avg Koninklijke KPN N.V. 16.2 avg Abiomed, Inc. 16.2 avg M-I L.L.C. 16.2 avg

Covidien's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

71 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Covidien LP patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	808	12.5%
2016	679	10.5%
2017	659	10.2%
2018	572	8.8%
2019	602	9.3%
2020	684	10.5%
2021	569	8.8%
2022	597	9.2%
2023	598	9.2%
2024	432	6.7%
2025partial year	285	4.4%

Which technologies does Covidien LP patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5,709

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 726

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 528

Y10T - Technical Subjects Covered BY Former US Classification 295

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 226

G06T - Image Data Processing OR Generation, IN General 198

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 174

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 152

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 93

G06F - Electric Digital Data Processing 83

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 79

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 64

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 59

F16H - Gearing 57

H01Q - Antennas, i.e. Radio Aerials 54

Top 15 of 183 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Covidien LP's patent record in context - here's where to go next.

Covidien LP's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 88% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #57 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Covidien LP against Honeywell International Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 70.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.